Financials

  • Market Capitalization 456.43 M
  • Employee 71
  • Founded 2010
  • CEO N/A
  • Website www.rezolutebio.com
  • Headquarter Nevada, United States
  • FIGI BBG001XWWHL4
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.55
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2974
PRTA
Prothena Corporation plc - Ordinary Shares
8.83 USD-4.44%-8.21%+0.68%+37.11%462.28 M USD
2977
STRO
Sutro Biopharma, Inc. - Common Stock
27.84 USD-6.36%-10.19%-3.33%+60.09%461.32 M USD
2986
VALN
Valneva SE - American Depositary Shares
5.26 USD+4.16%-0.75%-3.84%-19.45%456.41 M USD
2991
OVID
Ovid Therapeutics Inc. - Common Stock
2.43 USD-3.57%-7.25%+7.05%+507.50%453.54 M USD

新闻